Free Trial

LexinFintech (LX) Short Interest Ratio & Short Volume

$1.86
-0.01 (-0.53%)
(As of 05/28/2024 ET)

LexinFintech Short Interest Data

Current Short Interest
412,900 shares
Previous Short Interest
582,100 shares
Change Vs. Previous Month
-29.07%
Dollar Volume Sold Short
$788,639.00
Short Interest Ratio
0.4 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
164,130,000 shares
Float Size
128,400,000 shares
Short Percent of Float
0.32%
Today's Trading Volume
842,833 shares
Average Trading Volume
932,171 shares
Today's Volume Vs. Average
90%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling LexinFintech ?

Sign up to receive the latest short interest report for LexinFintech and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

LX Short Interest Over Time

LX Days to Cover Over Time

LX Percentage of Float Shorted Over Time

LexinFintech Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/2024412,900 shares $788,639.00 -29.1%0.3%0.4 $1.91
4/30/2024582,100 shares $977,928.00 -16.3%0.5%0.6 $1.68
4/15/2024695,300 shares $1.17 million -5.0%N/A0.6 $1.68
3/31/2024731,900 shares $1.32 million -36.4%N/A0.7 $1.80
3/15/20241,150,000 shares $2.13 million -9.5%N/A1.1 $1.85
2/29/20241,270,000 shares $2.34 million +7.6%N/A1.6 $1.84
2/15/20241,180,000 shares $2.17 million +4.4%N/A1.8 $1.84
1/31/20241,130,000 shares $2.05 million -0.9%N/A1.8 $1.81
1/15/20241,140,000 shares $2.27 million +45.7%N/A2.1 $1.99
12/31/2023782,600 shares $1.44 million +3.2%N/A1.6 $1.84
12/15/2023758,200 shares $1.39 million +14.0%N/A1.6 $1.83
11/30/2023665,400 shares $1.18 million -14.4%N/A1.6 $1.78
11/15/2023777,500 shares $1.57 million +8.5%N/A1.7 $2.02
10/31/2023716,900 shares $1.31 million +19.3%N/A1.7 $1.83
10/15/2023601,000 shares $1.20 million -7.6%N/A1.3 $1.99
9/30/2023650,200 shares $1.44 million -11.8%N/A1.4 $2.21
9/15/2023737,000 shares $1.65 million -13.5%N/A1.6 $2.24
8/31/2023851,700 shares $2.21 million +9.5%N/A1.7 $2.59
8/15/2023777,900 shares $1.80 million +1.1%N/A1.6 $2.32
7/31/2023769,600 shares $2.31 million -8.7%N/A1.7 $3.00
7/15/2023842,600 shares $2.15 million -7.7%N/A2.1 $2.55
6/30/2023913,000 shares $2.09 million +11.6%N/A2.5 $2.29
6/15/2023817,900 shares $2.07 million -4.6%N/A2 $2.53
5/31/2023857,400 shares $1.72 million -9.3%N/A1.8 $2.01
5/15/2023945,700 shares $2.47 million +13.9%N/A2 $2.61
4/30/2023830,600 shares $1.99 million -1.9%N/A1.6 $2.39
4/15/2023847,000 shares $2.16 million +4.9%N/A1.4 $2.55
3/31/2023807,300 shares $2.19 million +16.8%N/A1 $2.71
3/15/2023691,000 shares $1.64 million -22.6%N/A0.8 $2.38
2/28/2023892,500 shares $2.47 million +5.8%N/A1.1 $2.77
2/15/2023843,400 shares $2.66 million -5.0%N/A1 $3.15
1/31/2023887,900 shares $2.95 million +9.0%N/A1 $3.32
1/15/2023814,900 shares $2.72 million +10.0%N/A1 $3.34
12/30/2022741,000 shares $1.41 million -33.8%N/A0.9 $1.90
12/15/20221,120,000 shares $1.96 million -50.9%N/A1.6 $1.75
11/30/20222,280,000 shares $4.13 million -20.6%N/A3.5 $1.81
11/15/20222,870,000 shares $4.97 million +8.3%N/A4.5 $1.73
10/31/20222,650,000 shares $3.60 million +16.7%N/A3.9 $1.36
10/15/20222,270,000 shares $3.63 million +20.7%N/A3.2 $1.60
9/30/20221,880,000 shares $3.18 million +13.3%N/A2.5 $1.69
Revealed: The Unknown Biotech Powering AI in Healthcare (Ad)

The CEO of Google predicted this is "one of the most important things for humanity." We're standing at the brink of an AI revolution in medicine, a leap forward that will change the future medicine as we know it. If you're only watching tech giants like NVIDIA and Google for AI investments, you're missing the biggest opportunities... Because I've uncovered a little known biotech at the heart of this AI medical revolution.

To discover the name and ticker of this hidden gem click here>>>>
9/15/20221,660,000 shares $3.17 million +16.9%N/A2 $1.91
8/31/20221,420,000 shares $2.90 million +13.6%N/A1.5 $2.04
8/15/20221,250,000 shares $2.49 million +0.8%N/A0.9 $1.99
7/31/20221,240,000 shares $2.33 million +9.7%N/A0.9 $1.88
7/15/20221,130,000 shares $2.34 million +69.8%N/A0.8 $2.07
6/30/2022665,700 shares $1.48 million +48.5%N/A0.4 $2.23
6/15/2022448,200 shares $873,990.00 -14.7%N/A0.2 $1.95
5/31/2022525,300 shares $1.06 million -34.2%N/A0.2 $2.02
5/15/2022798,000 shares $1.81 million -47.5%N/A0.4 $2.27
4/30/20221,520,000 shares $3.89 million -18.7%N/A0.7 $2.56
4/15/20221,870,000 shares $4.64 million -27.0%N/A0.9 $2.48
3/31/20222,560,000 shares $6.71 million -35.7%N/A1.2 $2.62
3/15/20223,980,000 shares $8.60 million +9.0%N/A1.9 $2.16
2/28/20223,650,000 shares $12.96 million -0.3%N/A2.1 $3.55
2/15/20223,660,000 shares $14.57 million +28.4%N/A2 $3.98
1/31/20222,850,000 shares $10.20 million +8.8%N/A1.5 $3.58
1/15/20222,620,000 shares $9.14 million +30.4%N/A1.4 $3.49
12/31/20212,010,000 shares $7.76 million +16.9%N/A1.1 $3.86
12/15/20211,720,000 shares $6.67 million +3.0%N/A1 $3.88
11/30/20211,670,000 shares $7.01 million -37.0%N/A1 $4.20
11/15/20212,650,000 shares $16.72 million +23.8%N/A1.6 $6.31
10/29/20212,140,000 shares $11.43 million +21.6%N/A1.3 $5.34
10/15/20211,760,000 shares $9.89 million -32.8%N/A1 $5.62
9/30/20212,620,000 shares $15.43 million +5.2%N/A1.6 $5.89
9/15/20212,490,000 shares $15.66 million -13.2%N/A1.3 $6.29
8/31/20212,870,000 shares $19.98 million +47.2%N/A1.4 $6.96
8/13/20211,950,000 shares $13.61 million +30.9%N/A1 $6.98
7/30/20211,490,000 shares $11.71 million +64.6%N/A0.8 $7.86
7/15/2021905,300 shares $9.28 million -31.4%N/A0.5 $10.25
6/30/20211,320,000 shares $16.17 million +9.1%N/A0.8 $12.25
6/15/20211,210,000 shares $15.56 million -38.0%N/A0.8 $12.86
5/28/20211,950,000 shares $17.82 million +32.7%N/A1.2 $9.14
5/14/20211,470,000 shares $0.00 -40.0%N/A1.1 $0.00
4/30/20212,450,000 shares $22.54 million +3.8%N/A1.2 $9.20
4/15/20212,360,000 shares $21.71 million -8.2%N/A0.9 $9.20
3/31/20212,570,000 shares $25.65 million +37.4%N/A0.9 $9.98
3/15/20211,870,000 shares $24.96 million -17.6%N/A0.6 $13.35
2/26/20212,270,000 shares $25.79 million -22.5%N/A0.8 $11.36
2/12/20212,930,000 shares $36.07 million -49.2%N/A1 $12.31
1/29/20215,770,000 shares $43.62 million -16.0%N/A2.4 $7.56
1/15/20216,870,000 shares $45.07 million -12.7%N/A3.4 $6.56
12/31/20207,870,000 shares $53.04 million +6.1%N/A4.9 $6.74
12/15/20207,420,000 shares $49.49 million +14.5%N/A5 $6.67
11/30/20206,480,000 shares $48.08 million +53.2%N/A4.2 $7.42
11/15/20204,230,000 shares $34.18 million +5.8%N/A2.6 $8.08
10/30/20204,000,000 shares $34.36 million -44.9%N/A2.3 $8.59
10/15/20207,260,000 shares $50.09 million -8.3%N/A4.3 $6.90
9/30/20207,920,000 shares $54.25 million +3.9%N/A4.1 $6.85
9/15/20207,620,000 shares $59.28 million +17.4%N/A3.8 $7.78
8/31/20206,490,000 shares $50.69 million +3.5%N/A3 $7.81
Revealed: The Unknown Biotech Powering AI in Healthcare (Ad)

The CEO of Google predicted this is "one of the most important things for humanity." We're standing at the brink of an AI revolution in medicine, a leap forward that will change the future medicine as we know it. If you're only watching tech giants like NVIDIA and Google for AI investments, you're missing the biggest opportunities... Because I've uncovered a little known biotech at the heart of this AI medical revolution.

To discover the name and ticker of this hidden gem click here>>>>
8/14/20206,270,000 shares $52.86 million -4.6%N/A2.9 $8.43
7/31/20206,570,000 shares $55.91 million +6.5%N/A3.3 $8.51
7/15/20206,170,000 shares $70.03 million No ChangeN/A3.2 $11.35
6/30/20206,170,000 shares $65.59 million +31.3%N/A3.7 $10.63
6/15/20204,700,000 shares $48.27 million +13.8%N/A2.7 $10.27
5/29/20204,130,000 shares $33.66 million -8.4%N/A2.6 $8.15
5/15/20204,510,000 shares $37.16 million +12.2%N/A3 $8.24
4/30/20204,020,000 shares $34.89 million +26.4%N/A2.6 $8.68
4/15/20203,180,000 shares $27.25 million -8.9%3.1%1.9 $8.57
3/31/20203,490,000 shares $27.75 million -3.8%3.4%1.8 $7.95
3/13/20203,628,900 shares $31.54 million +17.4%3.5%2 $8.69
2/28/20203,090,000 shares $25.09 million +39.2%3.0%1.7 $8.12
2/14/20202,220,000 shares $21.96 million +32.9%N/A1.3 $9.89
1/31/20201,670,000 shares $20.01 million -18.5%N/A1 $11.98
1/15/20202,050,000 shares $27.33 million +49.6%N/A1.3 $13.33
12/31/20191,370,000 shares $20.58 million -6.2%N/A1 $15.02
8/15/2019704,100 shares $7.12 million -8.9%0.7%0.8 $10.11

LX Short Interest - Frequently Asked Questions

What is LexinFintech's current short interest?

Short interest is the volume of LexinFintech shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 412,900 shares of LX short. 0.32% of LexinFintech's shares are currently sold short. Learn More on LexinFintech's current short interest.

What is a good short interest percentage for LexinFintech?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.32% of LexinFintech's floating shares are currently sold short.

Is LexinFintech's short interest increasing or decreasing?

LexinFintech saw a decline in short interest in May. As of May 15th, there was short interest totaling 412,900 shares, a decline of 29.1% from the previous total of 582,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is LexinFintech's float size?

LexinFintech currently has issued a total of 164,130,000 shares. Some of LexinFintech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. LexinFintech currently has a public float of 128,400,000 shares.

How does LexinFintech's short interest compare to its competitors?

0.32% of LexinFintech's shares are currently sold short. Here is how the short interest of companies in the sector of "finance" compare to LexinFintech: HIVE Digital Technologies Ltd. (3.71%), Greystone Housing Impact Investors LP (0.10%), MDB Capital Holdings, LLC (0.00%), Security National Financial Co. (0.59%), X Financial (0.00%), Medallion Financial Corp. (6.03%), Runway Growth Finance Corp. (3.60%), Oportun Financial Co. (0.74%), Bitcoin Depot Inc. (5.94%), CNFinance Holdings Limited (0.01%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short LexinFintech stock?

Short selling LX is an investing strategy that aims to generate trading profit from LexinFintech as its price is falling. LX shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against LexinFintech?

A short squeeze for LexinFintech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LX, which in turn drives the price of the stock up even further.

How often is LexinFintech's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LX, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:LX) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners